AH EQUITY PARTNERS BIO II, L.L.C. sold 83.7% of their position (5M shares) of NAUTILUS BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $11.75M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/4/2026ACC: 0001231919-26-000599
10% Owner
Since Jun 2021
-5M
Net shares
Net seller
$11.75M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
5M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−4.62M
Price / share
$2.35
Trade value
$10.85M
% of position
28.3%
6/2/2026
16.30M→11.68M
Common Stock
Indirect
Shares
−384.03K
Price / share
$2.35
Trade value
$902.46K
% of position
28.3%
6/2/2026
1.36M→971.88K
Total
Net shares
−5M
Net value
-$11.75M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/2/2026 | S · Sale | −4.62M | $2.35 | $10.85M | 28.3% | 16.30M | 11.68M |
| Common Stock Indirect | 6/2/2026 | S · Sale | −384.03K | $2.35 | $902.46K | 28.3% | 1.36M | 971.88K |
| Total | −5M | -$11.75M | ||||||
Derivative Transactions0
No derivative transactions reported